Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2020;31(3):341-9
Association of Musculoskeletal and Radiological Features with Clinical and Serological Findings in Systemic Sclerosis: A Single-Centre Registry Study
Authors Information

1. Arak University of Medical Sciences, Arak, Iran

2. Iran University of Medical Sciences, Tehran, Iran

3. Tehran University of Medical Sciences, Tehran, Iran

References
  1. Varjú C, Péntek M, Lóránd V, Nagy G, Minier T, Czirják L. Musculoskeletal involvement in systemic sclerosis: an unexplored aspect of the disease. JSRD 2017;1:19-32.
  2. Johnson SR, Glaman DD, Schentag CT, Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 2006;6:1117-22.
  3. Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) 2011;4:762-7.
  4. Skare TL, Toebe BL, Boros C. Hand dysfunction in scleroderma patients. Sao Paulo Med J 2011;5:357-60.
  5. Avouac J, Walker U, Tyndall A, Kahan A, Matucci-Cerinic M, Allanore Y. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis:results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 2010;7:1488-501.
  6. Avouac J, Guerini H, Wipff J, Assous N, Chevrot A, Kahan A, et al. Radiographic hand involvement in systemic sclerosis. Ann Rheum Dis 2006;8:1088-92.
  7. La Montagna G, Sodano A, Capurro V, Malesci D, Valentini G. The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiol 2005;1:35-41.
  8. Ingegnoli F, Galbiati V, Zeni S, Meani L, Zahalkova L, Lubatti C, et al. Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 2007;4:510-4.
  9. Ostojić P, Damjanov N. Indices of the Scleroderma Assessment Questionnaire (SAQ) can be used to demonstrate change in patients with systemic sclerosis over time. Joint Bone Spine 2008;3:286-90.
  10. Ostojić P, Damjanov N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol 2006;4:453-7.
  11. Foocharoen C, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases. J Med Assoc Thai 2014;1:28-35.
  12. Chan PT, Mok CC, Chan KL, Ho LY. Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study. Clin Rheumatol 2014;5:659-66.
  13. Rosenbaum LH, Swartz WM, Rodnan GP, Medsger TA Jr. Wrist drop in progressive systemic sclerosis (scleroderma): complete rupture of the extensor tendon mechanism. Arthritis Rheum 1985;5:586-9.
  14. Baron M, Lee P, Keystone EC. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis 1982;2:147-52.
  15. Sandqvist G, Eklund M, Akesson A, Nordenskiold U. Daily activities and hand function in women with scleroderma. Scand J Rheumatol 2004;2:102-7.
  16. Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J, et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 2007;1:94-102.
  17. Clements PJ, Allanore Y, Khanna D, Singh M, Furst DE. Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis. Semin Arthritis Rheum 2012;6:801-4.
  18. Allanore Y, Seror R, Chevrot A, Kahan A, Drapé JL. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum 2007;8:2747-54.
  19. 19.Avouac J, Clements PJ, Khanna D, Furst DE, Allanore Y. Articular involvement in systemic sclerosis. Rheumatology (Oxford) 2012;8:1347-56.
  20. Hyphantis TN, Tsifetaki N, Siafaka V, Voulgari PV, Pappa C, Bai M, et al. The impact of psychological functioning upon systemic sclerosis patient’s quality of life. Semin Arthritis Rheum 2007;2:81-92.
  21. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Ann Rheum Dis 2013;11:1747-55.
  22. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol 1988;15:202-20.
  23. Torok KS, Baker NA, Lucas M, Domsic RT, Boudreau R, Medsger TA Jr. Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol 2010;28:S28-36.
  24. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21(Suppl. 29):S42-S46.
  25. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-63.
  26. Tolédano C, Gain M, Kettaneh A, Baudin B, Johanet C, Chérin P, et al. Aldolase predicts subsequent myopathy occurrence in systemic sclerosis. Arthritis Res Ther 2012;3:R152.
  27. Steen VD, Medsger TA Jr. The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 1997;40:1146-51.
  28. Doré A, Lucas M, Ivanco D, Medsger TA Jr, Domsic RT. Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis. Arthritis Care Res 2013;8:1385-9.
  29. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006;7:845-51.
  30. Ueda-Hayakawa I, Hasegawa M, Kumada S, Tanaka C, Komura K, Hamaguchi Y, et al. Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis. Rheumatology (Oxford) 2010;11:2135-9.
  31. Liaskos C, Marou E, Simopoulou T, Gkoutzourelas A, Barmakoudi M, Efthymiou G, et al. Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece. Mediterr J Rheumatol 2018;29(3):120-6.
  32. Poormoghim H, Moghadam AS, Moradi-Lakeh M, Jafarzadeh M, Asadifar B, Ghelman M, et al. Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients. Rheumatol Int 2013 ;33:1943-50.
  33. Allanore Y, Gharibdoost F, Jamshidi AR, Javinani A, Avouac J, Rastkar E, et al. Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers. JSRD 2018;4(2):239719831880922.
  34. Elhai M, Guerini H, Bazeli R, Avouac J, Freire V, Drapé J-L, et al. Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings. Arthritis Care Res (Hoboken) 2012;64:1244-9.